This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Hristova AH, Joseph LN, Sathe SA, Wade JB.Severe Nervous System Complications After Botulinum Type A Therapy: Three Case Reports With Reviews of FDA-Reported Nervous System Adverse Effects. P M and R - The Journal of Injury, Function and Rehabilitation 4: 613-623, No. 8, Aug 2012. Available from: URL: http://dx.doi.org/10.1016/j.pmrj.2012.04.016 - USA
Additional information
Key words
Apraxias; Vomiting; Exanthema; Memory-disorders; Headache; Neurological-disorders; Fatigue; Somnolence; adverse reactions; Muscle-weakness; Urinary-incontinence; Tachycardia; Botulinum-toxin-A; drug-induced; Gait-disturbances; Confusion; Fever; Nausea; Lethargy; Blurred-vision; Hiccup; Dysarthria
An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage
Rights and permissions
About this article
Cite this article
Botulinum toxin A. React. Wkly. 1426, 14 (2012). https://doi.org/10.2165/00128415-201214260-00047
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201214260-00047